This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Post COVID GI disorders refer to gastrointestinal (GI) problems that may arise in individuals who have recently recovered from COVID-19. These GI problems can range from mild symptoms such as abdominal pain and nausea, to more severe symptoms including bleeding and inflammation. While the exact cause of post-COVID GI disorders is still not fully understood, it is believed to be related to the body's immune response to the virus. The most common post-COVID GI disorder is called “gastrointestinal dysmotility”. This condition is characterized by a disruption in the normal functioning of the GI tract, resulting in a range of symptoms such as abdominal pain, constipation, diarrhoea, nausea, and vomiting. It is important to note that post-COVID GI disorders can be difficult to diagnose as many of their symptoms overlap with other conditions such as irritable bowel syndrome (IBS). Additionally, due to the recent nature of the pandemic, there is still a lot to learn about the long-term health effects of COVID-19. Fortunately, there are treatment options available to individuals who are suffering from post-COVID GI disorders. These treatments include dietary changes, lifestyle modifications, probiotics, and medications.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States